RE:Real Possibilities And Great Potential.Agreed, the potential is really big, based on what we can read. And the desire to close acqusitions over the next quarter should help SP appreciate.
Surprised this remains so under the radar. Market cap is still tiny, given the assets, lack of debt, and acquisition plans.
{As an aside, it doesn't help SGMD's exposure that Stockhouse has completely bungled the new Message Bullboard for this stock, so our posts (including this one, I presume) get filed under "V.SGMD_OLD" on our member profile, which then cannot be retrieved through anyone's profile page -- making the posts and the BOARD itself even more obscure than it should be.... lol. I sent a msg to SH, but of course there was no response. We'll see if it gets fixed eventuallly.}
... Meanwhile, looking forward to some big announcements from SGMD in coming weeks.
goldennorth wrote: Experence and very industry knowledable managment. Management’s personal relationships with business owners and executives throughout the industry allows the Company to get access to decision makers and potential targets quickly and effectively.
Salona’s strategy is to acquire companies, paying private company multiples, predominantly through earn-outs heavy in stock. Earn out structures help to keep float tight and allow the company to ensure cash flow and revenue is earned in advance of payment.
SGMD has a deep and full pipeline of potential acquisition targets – all medical device companies with between $5M - $20M in revenues w/ cash flow.
This stock has excellent fundamentals and great price momentum. by Thomson Reuters Stock Reports. It's going to continue to move up and could easly be trading at $2.00 or more by the mid July. It's a good buy.
https://2e0c9480-053d-40d5-b81e-656a8b3c8346.filesusr.com/ugd/3c6412_6b173990300d4e32bb53252bee95fd55.pdf